Risk factors for haemorrhage in patients with haematological malignancies

<p>Haematological malignancies and their treatment lead to prolonged periods of severe thrombocytopenia (platelet count ≤ 50 x 10<sup>9</sup>/l). Despite the use of prophylactic platelet transfusions, haemorrhage remains an important complication during this thrombocytopenic period...

Celý popis

Podrobná bibliografie
Hlavní autor: Estcourt, LJ
Další autoři: Murphy, MF
Médium: Diplomová práce
Jazyk:English
Vydáno: 2014
Témata: